GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,415,472 | -58.3% | 28,509 | -50.0% | 0.98% | -17.9% |
| Q2 2023 | $3,394,852 | +110.2% | 57,018 | +100.0% | 1.19% | -14.8% |
| Q1 2023 | $1,614,750 | +76175.4% | 28,509 | 0.0% | 1.40% | -23.5% |
| Q4 2022 | $2,117 | -99.9% | 28,509 | 0.0% | 1.83% | +32.4% |
| Q3 2022 | $1,698,000 | +6.1% | 28,509 | 0.0% | 1.38% | +8.8% |
| Q2 2022 | $1,600,000 | -23.9% | 28,509 | 0.0% | 1.27% | +1.4% |
| Q1 2022 | $2,103,000 | +2.2% | 28,509 | 0.0% | 1.25% | +19.6% |
| Q4 2021 | $2,058,000 | -5.8% | 28,509 | 0.0% | 1.05% | -3.0% |
| Q3 2021 | $2,184,000 | -1.2% | 28,509 | 0.0% | 1.08% | -7.5% |
| Q2 2021 | $2,210,000 | +25.7% | 28,509 | 0.0% | 1.17% | +27.3% |
| Q1 2021 | $1,758,000 | -5.4% | 28,509 | 0.0% | 0.92% | -2.0% |
| Q4 2020 | $1,859,000 | +31.7% | 28,509 | 0.0% | 0.94% | +13.9% |
| Q3 2020 | $1,412,000 | -40.8% | 28,509 | -43.0% | 0.82% | -39.1% |
| Q2 2020 | $2,385,000 | – | 50,000 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |